Public Employees Retirement System of Ohio Buys Shares of 30,490 Henry Schein, Inc. $HSIC

Public Employees Retirement System of Ohio purchased a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 30,490 shares of the company’s stock, valued at approximately $2,547,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Ameriprise Financial Inc. boosted its holdings in Henry Schein by 3,275.2% during the second quarter. Ameriprise Financial Inc. now owns 2,266,858 shares of the company’s stock worth $165,594,000 after purchasing an additional 2,199,695 shares during the last quarter. Bank of Montreal Can increased its stake in Henry Schein by 3,655.7% in the 4th quarter. Bank of Montreal Can now owns 2,144,773 shares of the company’s stock valued at $162,102,000 after buying an additional 2,087,666 shares during the last quarter. Norges Bank bought a new stake in Henry Schein during the 4th quarter worth about $88,116,000. Southpoint Capital Advisors LP lifted its position in Henry Schein by 28.0% during the 1st quarter. Southpoint Capital Advisors LP now owns 3,200,000 shares of the company’s stock worth $235,840,000 after buying an additional 700,000 shares in the last quarter. Finally, Bank of America Corp DE boosted its stake in shares of Henry Schein by 204.2% during the 2nd quarter. Bank of America Corp DE now owns 995,375 shares of the company’s stock worth $72,712,000 after buying an additional 668,182 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have recently weighed in on HSIC. Citigroup restated a “buy” rating and issued a $112.00 price objective (up from $100.00) on shares of Henry Schein in a report on Wednesday, August 5th. BMO Capital Markets began coverage on Henry Schein in a report on Wednesday, July 8th. They set a “market perform” rating and a $85.00 target price on the stock. UBS Group set a $94.00 price target on Henry Schein and gave the company a “neutral” rating in a research report on Wednesday, August 5th. Stifel Nicolaus set a $95.00 price target on Henry Schein in a research note on Wednesday, August 5th. Finally, Wall Street Zen raised Henry Schein from a “hold” rating to a “buy” rating in a research report on Monday, August 17th. Nine research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Henry Schein currently has a consensus rating of “Moderate Buy” and an average target price of $92.93.

Henry Schein Trading Down 1.2%

Shares of NASDAQ:HSIC opened at $89.81 on Friday. Henry Schein, Inc. has a 52-week low of $61.94 and a 52-week high of $92.18. The company has a market capitalization of $10.01 billion, a P/E ratio of 26.18, a price-to-earnings-growth ratio of 1.71 and a beta of 0.81. The company has a 50-day simple moving average of $87.47 and a 200 day simple moving average of $80.35. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.73 and a current ratio of 1.32.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $1.27 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.03. Henry Schein had a return on equity of 15.97% and a net margin of 2.96%.The firm had revenue of $3.46 billion for the quarter, compared to the consensus estimate of $3.37 billion. During the same quarter in the previous year, the business earned $1.10 earnings per share. The business’s revenue was up 6.7% compared to the same quarter last year. Henry Schein has set its FY 2026 guidance at 5.290-5.390 EPS. Sell-side analysts forecast that Henry Schein, Inc. will post 5.36 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.